Gilead's Descovy receives FDA approval to treat HIV

American biopharmaceutical company Gilead Sciences has secured approval from the US Food and Drug Administration (FDA) for Descovy (emtricitabine 200mg/tenofovir alafenamide 25mg, F/TAF) to treat patients with HIV.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news